2021 Report details for project: Replacement Analytical Project

Project name Replacement Analytical Project - there are 3 reports for this project: 2021, 2022, 2023
Google search Google search on project name (opens in new window) opens in new window
Contracts Contracts search (opens in new window) opens in new window - under development
Organisation BEIS (D1198) - see all reports for this organisation
Report year 2021 (data is from March 2021)
Category Infrastructure - see all reports for this category
Description: The Replacement Analytical Project is a key component of the Analytical Services Programme, which provides essential services to operations on the Sellafield Site supporting 22 Programmes & approximately 200 Operational Facilities. The existing facility is 60 years old and cannot provide long-term capability so new analytical facilities need to be established. The Replacement Analytical Project has therefore been initiated to deliver future analytical capability to the Sellafield site, through a major modification of the National Nuclear Laboratory Central Laboratory. Key modifications are provision of standalone Highly Active (HA), Medium Active (MA) and Special Nuclear Material (SNM) analytical capability. A key part of the scope is the delivery of 135 Analytical Instruments which will perform the ongoing analysis required by facilities at Sellafield. Analytical Services remains essential to the delivery of high hazard reduction and remediation until the completion of the Sellafield Ltd mission.
DCA (RAG) Amber
DCA text: The Infrastructure Project Authority's Delivery Confidence Assessment rating is Amber.This is primarily due to the following factors: The project is made up of a number of workstreams the last of which is due to complete the preliminary design phase in July 21. The delivery of the detailed design will take until Jan 24 and then the Full Business Case will be produced and submitted. The project has had design slippage in the current phase and is forecasting slippage of the detailed design. This is due mainly to COVID and the late placement of contracts to support the development of the analytical equipment and also partly due to performance issues. Given the early maturity of the project in the preliminary design phase and typically for projects at this stage, the lifetime schedule for future phases is not underpinned and is likely to change as the project matures. Importantly the project has a strategic tolerance to support completion of analytical services in the existing facility by Dec 2030.
Start date 2016-09-26
End date 2028-07-10
Schedule text The project end-date is 10 July 2028. This is primarily due to the following factors: The baseline end date is 10th July 2028. However, the Latest forecast of 9th Nov 2028 for completion of project support to active commissioning reflects a 4 month slippage from the Outline Business Case and baseline date, with the significant factors being the impact of COVID and supply chain contract delays. Given the early maturity of the project in the preliminary design phase and typically for projects at this stage, the lifetime schedule for future phases is not underpinned and is likely to change as the project matures.
Baseline £36.19m
Forecast £28.69m
Variance -21.00%
Variance text: The budget variance exceeds 5%. The budget of £36.19m represents the planned scope to be delivered against the plan put in place in 2019, which compares to a forecast of actual scope to be delivered at £24.23m, at a cost of £28.69m. The project has delivered less scope than originally planned due to the multiple impacts of COVID19; design deliverables delayed due to revised working arrangements and restrictions, limited site access throughout the year causing delays to early construction enabling works and delays placing supply chain contracts with staff being furloughed. The actual scope delivered has cost more than planned primarily due to the impact of COVID 19 resulting in reduced productivity and inefficient working.
Whole Life Cost £643.54m
WLCost text: The projects Baseline Whole Life Cost is £643.54m. This is primarily due to the following factors: The current baseline of £643.54m reflects the P50 (a probability of 50% to deliver for the cost) cost profile in the Outline Business Case, escalated into 2020/21 money values and incorporating the cumulative positive cost variance up to 2018/19. Given the relative immaturity of the project the P80 (a probability of 80% to deliver for the cost) is £800M and the upper range is £1Bn from the Outline Business Case in 2019/20 money values (P80 escalated is £878m).
Notes1:
Notes2:
Sourcefile IPA_2021.csv

Home Selection Search All Reports Projects +dates Projects +costs Organisations Years Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.